US Stock MarketDetailed Quotes
CDT Conduit Pharmaceuticals
- 0.105
- +0.007+6.80%
Close Nov 5 16:00 ET
- 0.102
- -0.003-2.85%
Pre 05:50 ET
10.60MMarket Cap-1282P/E (TTM)
0.113High0.088Low12.99MVolume0.093Open0.099Pre Close1.36MTurnover23.62%Turnover RatioLossP/E (Static)100.77MShares7.83052wk High-1.95P/B5.79MFloat Cap0.07952wk Low--Dividend TTM55.01MShs Float25.000Historical High--Div YieldTTM25.48%Amplitude0.079Historical Low0.104Avg Price1Lot Size
About Conduit Pharmaceuticals Company
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.
Company Profile
SymbolCDT
Company NameConduit Pharmaceuticals
Listing DateMar 28, 2022
CEOMr. David Tapolczay
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address4995 Murphy Canyon Road,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92123
Phone1-760-471-8536
Websitehttp://www.conduitpharma.com
Company Executives
- Name
- Position
- Salary
- David Tapolczay
- Chief Executive Officer and Director
- 1.34M
- James Bligh
- Director, Senior Vice President, Strategy and Interim Chief Financial Officer
- --
- Dr. Freda C. Lewis-Hall,M.D.
- Chairman of the Board
- 275.31K
- Dr. Andrew James Regan
- Director
- 842.08K
- Faith L. Charles
- Independent Director
- 267.43K
- Chele Chiavacci Farley
- Independent Director
- 268.93K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data